Protalix BioTherapeutics, Inc. (PLX): Shares Outstanding
80.43M
As of 2025-12-31
+14.3%
3-year compound annual growth
+18.3%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 80.43M | +6.0% | 2026-03-18, Balance as of period end |
| 2024-12-31 | 75.85M | +4.0% | 2026-03-18, Balance as of period end |
| 2023-12-31 | 72.95M | +35.6% | 2025-03-17, Balance as of period end |
| 2022-12-31 | 53.79M | +18.1% | 2024-03-14, Balance as of period end |
| 2021-12-31 | 45.56M | +31.0% | 2023-02-27, Balance as of period end |
| 2020-12-31 | 34.77M | +134.3% | 2022-03-31, Balance as of period end |
| 2019-12-31 | 14.84M | 0.0% | 2021-03-30, Balance as of period end |
| 2018-12-31 | 14.84M | n/c | 2020-03-12, Balance as of period end |
| 2017-12-31 | 143.73M | +15.8% | 2019-03-18, Balance as of period end |
| 2016-12-31 | 124.13M | +24.4% | 2018-03-06, Balance as of period end |
| 2015-12-31 | 99.80M | +6.6% | 2017-03-16, Balance as of period end |
| 2014-12-31 | 93.60M | +0.1% | 2016-03-08, Balance as of period end |
| 2013-12-31 | 93.55M | +0.1% | 2015-03-12, Balance as of period end |
| 2012-12-31 | 93.49M | +9.2% | 2014-03-13, Balance as of period end |
| 2011-12-31 | 85.63M | +5.4% | 2013-02-28, Balance as of period end |
| 2010-12-31 | 81.25M | n/a | 2012-02-27, Balance as of period end |